Imbruvica Ibrutinib — United Healthcare
17 indications indexed for this drug.
- B Cell LymphomaView coverage criteria
- Chronic Graft Versus Host Disease CgvhdView coverage criteria
- Chronic Lymphocytic Leukemia CllView coverage criteria
- Diffuse Large B Cell Lymphoma Non Gcb Dlbcl And Non CandidatView coverage criteria
- Extranodal Marginal Zone Lymphoma Emzl Of Nongastric Sites NView coverage criteria
- Extranodal Marginal Zone Lymphoma Emzl Of The StomachView coverage criteria
- Hairy Cell LeukemiaView coverage criteria
- High Grade B Cell LymphomaView coverage criteria
- Histologic Transformation To Diffuse Large B Cell LymphomaView coverage criteria
- Hiv Related B Cell LymphomaView coverage criteria
- Lymphoplasmacytic LymphomaView coverage criteria
- Mantle Cell Lymphoma MclView coverage criteria
- Nodal Or Splenic Marginal Zone Lymphoma MzlView coverage criteria
- Post Transplant Lymphoproliferative DisordersView coverage criteria
- Primary Cns LymphomaView coverage criteria
- Small Lymphocytic Lymphoma SllView coverage criteria
- Waldenstr M S MacroglobulinemiaView coverage criteria